Daniel Petroni
Allergy & Immunology · Seattle, WANPI 1073808028
Payments from drug & device makers
Across 762 payments — averaging $2679.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$913K
- Aimmune Therapeutics, Inc.$445K
- Novartis$263K
- AstraZeneca$165K
- Takeda Pharmaceuticals U.S.A., Inc.$98K
- Biocryst Pharmaceuticals, Inc.$70K
- plus $88K from 23 others
Across 4 payments — averaging $362.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 129 | $913,266 |
| Aimmune Therapeutics, Inc. | 256 | $444,671 |
| Novartis | 28 | $262,773 |
| AstraZeneca | 71 | $164,522 |
| Takeda Pharmaceuticals U.S.A., Inc. | 124 | $98,199 |
| Biocryst Pharmaceuticals, Inc. | 8 | $70,228 |
| Amphastar Pharmaceuticals, Inc. | 1 | $23,264 |
| Astrazeneca UK Limited | 13 | $18,914 |
| Blueprint Medicines Corporation | 22 | $15,046 |
| GSK | 10 | $9,521 |
| Biocryst US Sales Co., LLC | 7 | $5,965 |
| Genentech, Inc. | 7 | $5,683 |
| Jubilant Hollisterstier LLC | 2 | $4,000 |
| Sanofi | 21 | $2,821 |
| AbbVie | 4 | $995 |
| Incyte Corporation | 11 | $691 |
| Alk-abello, Inc | 3 | $341 |
| Pfizer | 20 | $287 |
| Genentech USA, Inc. | 2 | $158 |
| Boehringer Ingelheim | 3 | $144 |
| Amgen | 5 | $116 |
| Kaleo, Inc. | 5 | $103 |
| ADMA Biomanufacturing LLC | 2 | $54 |
| Sanofi Pasteur Inc. | 1 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| CSL Behring | 1 | $27 |
| Optinose US, Inc. | 1 | $25 |
| Merck | 1 | $21 |
How this compares
$2,041,948 in reported general payments places this provider in the 95th percentile of 81 allergy & immunology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Seattle
- William HendersonSeattle$296K
- Mary FarringtonSeattle$176K
- Frank VirantSeattle$107K
- Leonard AltmanSeattle$81K
- Stephen TillesSeattle$59K
- Rahool DaveSeattle$47K
- Matthew AltmanSeattle$37K
- Gabriel MendozaSeattle$16K
- Kelly ColasSeattle$14K
- Jing Yi SunSeattle$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.